Screener
NovoCure NVCR CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 | Year ended December 31, 2025 |
|---|---|---|---|---|---|
| Increase (decrease) in other long-term liabilities | (2,789) | 920 | (5,626) | (201) | (5,274) |
| Net cash provided by (used in) operating activities | $8,132 | $(15,936) | (5,385) | (51,601) | (49,031) |
| Cash flows from investing activities: | |||||
| Purchase of property, equipment and field equipment | $(6,916) | $(5,486) | (12,068) | (16,097) | (26,648) |
| Proceeds from maturity of short-term investments | 95,000 | 420,000 | 205,000 | 540,000 | 1,285,000 |
| Purchase of short-term investments | (94,462) | (378,528) | (191,563) | (494,389) | (821,076) |
| Net cash provided by (used in) investing activities | $(6,378) | $35,986 | 1,369 | 29,514 | 437,276 |
| Cash flows from financing activities: |
Item 1. Financial Statements
FAQ
- What is NovoCure's capex?
- NovoCure (NVCR) reported capex of $6.92M in Q2 2026.
- How has NovoCure's capex changed year-over-year?
- NovoCure's capex increased by 26.1% year-over-year, from $5.49M to $6.92M.
- What is the long-term trend for NovoCure's capex?
- Over 4 years (2021 to 2025), NovoCure's capex has grown at a 2.5% compound annual growth rate (CAGR), from $24.17M to $26.65M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about NovoCure's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude